Briony Sue Chisholm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Briony Sue Chisholm has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Marc Blockman
Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
3 shared publications- Marc Blockman
Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
3 shared publications - Annoesjka Swart
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
2 shared publications Catherine Orrell
Desmond Tutu HIV Centre, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
2 shared publications- Karen Cohen
Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
2 shared publications - Annemie Stewart
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
1 shared publication
Latest Publications
- Open Access
- 6 March 2025
- Published by Elsevier in Nurse Education in Practice
- Vol. 86, 104326
Effectiveness and uptake of WhatsApp-based HIV microlearning for healthcare workers in remote South African clinics: A pragmatic, mixed-methods, cluster-randomised trial
- 6 March 2025
- Published by Elsevier in Nurse Education in Practice
- Vol. 86, 104326
Open AccessEffectiveness and uptake of WhatsApp-based HIV microlearning for healthcare workers in remote South African clinics: A pragmatic, mixed-methods, cluster-randomised trial
- Open Access
- 1 January 2024
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 23
A Mixed Methods, Cluster-Randomised Study Protocol to Design and Test WhatsApp Group-Based HIV Microlearning for Rural South African Healthcare Workers
Treatment of HIV in South Africa is informed by national guidelines, which are regularly updated. Ongoing training of healthcare workers is vital for optimal patient care, but is challenging, due to human, financial and infrastructural constraints. There is a need for innovative solutions to meet training and support needs. With 93.2% of South African adults using WhatsApp, it is an ideal platform for training, even in the most remote clinics. The primary aim of the study is to design, test and evaluate the effect of WhatsApp group-based HIV training on nurses’ and community health workers’ knowledge. The secondary aims are to assess uptake, acceptability, and feasibility of the intervention; and to explore and describe the changes in prescribing, comparing the intervention group to the control group. A pragmatic, mixed-methods, parallel-group cluster-randomised study design will be used. This paper details the design – and rationale behind it – of the study. A critical realist stance was chosen, with outcomes measured using questionnaires, pre- and post-intervention; WhatsApp group interaction; focus groups; and folder reviews. Inferential analysis will be conducted using Stata, descriptive analysis using Excel™ and qualitative data using template analysis with NVivo™. Rigor of the study will be ensured using relevant points from the CASP and COREQ checklists, considering the study’s theoretical underpinning, design and aims. Reporting will be guided by the CONSORT and SRQR guidelines.
- 1 January 2024
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 23
Open AccessA Mixed Methods, Cluster-Randomised Study Protocol to Design and Test WhatsApp Group-Based HIV Microlearning for Rural South African Healthcare Workers
Treatment of HIV in South Africa is informed by national guidelines, which are regularly updated. Ongoing training of healthcare workers is vital for optimal patient care, but is challenging, due to human, financial and infrastructural constraints. There is a need for innovative solutions to meet training and support needs. With 93.2% of South African adults using WhatsApp, it is an ideal platform for training, even in the most remote clinics. The primary aim of the study is to design, test and evaluate the effect of WhatsApp group-based HIV training on nurses’ and community health workers’ knowledge. The secondary aims are to assess uptake, acceptability, and feasibility of the intervention; and to explore and describe the changes in prescribing, comparing the intervention group to the control group. A pragmatic, mixed-methods, parallel-group cluster-randomised study design will be used. This paper details the design – and rationale behind it – of the study. A critical realist stance was chosen, with outcomes measured using questionnaires, pre- and post-intervention; WhatsApp group interaction; focus groups; and folder reviews. Inferential analysis will be conducted using Stata, descriptive analysis using Excel™ and qualitative data using template analysis with NVivo™. Rigor of the study will be ensured using relevant points from the CASP and COREQ checklists, considering the study’s theoretical underpinning, design and aims. Reporting will be guided by the CONSORT and SRQR guidelines.
- Open Access
- 7 March 2022
- Published by Wiley in Journal of the International AIDS Society
- Vol. 25 (3) , e25885
South African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross‐sectional online survey
Introduction: In December 2019, dolutegravir‐based treatment was recommended as first‐line antiretroviral therapy (ART) in South Africa. Dolutegravir has clinically significant interactions with several commonly used drugs, such as rifampicin, metformin and cation‐containing medicines. National guidelines detail these interactions and how to manage them. While previous international studies have shown low healthcare worker knowledge of drug–drug interactions, there is a paucity of information on antiretroviral interaction knowledge in the South African setting, where much ART is nurse‐led. The study aimed to determine this knowledge and to describe which variables were associated with gaps in knowledge.Methods: An anonymous online survey of healthcare workers in the field of HIV was conducted in August/September 2020. The survey was designed, tested and piloted, and included sections on demographics, guideline access and training, interaction knowledge, counselling and the effect of COVID‐19. Dissemination was via e‐mail and social media (convenience sampling). Descriptive and inferential analysis was done using proportions and the 95% confidence interval to determine relationships between independent and dependent variables. Research ethics approval was obtained from the University of Cape Town's Human Research Ethics Committee (HREC Ref: 357/2020).Results and discussion: In total, 1950 survey responses were included in the analysis – 47.1% nurses, 35.8% doctors and 8.9% pharmacists. When asked whether they were aware that dolutegravir has interactions, 70% said yes, 13.9% said no and 16.1% did not answer. Knowledge of specific interactions and the dosing changes needed was low with a wide range between different drugs: 79.7% knew to double the dolutegravir dose with rifampicin, but with calcium, 5.1% picked both correct dosing options and 33.7% picked one of the two correct options. Access to guidelines and training were positively associated with drug interaction knowledge.Conclusions: There are gaps in the awareness and knowledge of dolutegravir interactions and how to adjust dosing among South African healthcare workers.
- 7 March 2022
- Published by Wiley in Journal of the International AIDS Society
- Vol. 25 (3) , e25885
Open AccessSouth African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross‐sectional online survey
Introduction: In December 2019, dolutegravir‐based treatment was recommended as first‐line antiretroviral therapy (ART) in South Africa. Dolutegravir has clinically significant interactions with several commonly used drugs, such as rifampicin, metformin and cation‐containing medicines. National guidelines detail these interactions and how to manage them. While previous international studies have shown low healthcare worker knowledge of drug–drug interactions, there is a paucity of information on antiretroviral interaction knowledge in the South African setting, where much ART is nurse‐led. The study aimed to determine this knowledge and to describe which variables were associated with gaps in knowledge.Methods: An anonymous online survey of healthcare workers in the field of HIV was conducted in August/September 2020. The survey was designed, tested and piloted, and included sections on demographics, guideline access and training, interaction knowledge, counselling and the effect of COVID‐19. Dissemination was via e‐mail and social media (convenience sampling). Descriptive and inferential analysis was done using proportions and the 95% confidence interval to determine relationships between independent and dependent variables. Research ethics approval was obtained from the University of Cape Town's Human Research Ethics Committee (HREC Ref: 357/2020).Results and discussion: In total, 1950 survey responses were included in the analysis – 47.1% nurses, 35.8% doctors and 8.9% pharmacists. When asked whether they were aware that dolutegravir has interactions, 70% said yes, 13.9% said no and 16.1% did not answer. Knowledge of specific interactions and the dosing changes needed was low with a wide range between different drugs: 79.7% knew to double the dolutegravir dose with rifampicin, but with calcium, 5.1% picked both correct dosing options and 33.7% picked one of the two correct options. Access to guidelines and training were positively associated with drug interaction knowledge.Conclusions: There are gaps in the awareness and knowledge of dolutegravir interactions and how to adjust dosing among South African healthcare workers.
- Open Access
- 16 November 2016
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 13 (1) , 1-5
Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
Gynaecomastia is associated with exposure to antiretroviral therapy (ART), in particular efavirenz. There is limited data on clinical characteristics of patients with ART-associated gynaecomastia in resource-limited settings and little guidance on the optimal management of this adverse drug reaction (ADR). We describe the clinical characteristics, management and outcomes of gynaecomastia cases reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa. We identified all gynaecomastia cases in adolescent boys and men on ART reported to the hotline between June 2013 and July 2014. We collected follow up data telephonically at monthly intervals to document clinical management and outcomes. We received 51 reports of gynaecomastia between June 2013 and July 2014; 11% of the 475 patient-specific ADR queries to the hotline. All patients were on efavirenz-based ART. Mean age was 34 years (standard deviation 12) and seven were adolescents. The median onset of gynaecomastia was 15 months after efavirenz initiation (interquartile range 6–42). Gynaecomastia was bilateral in 29 patients (57%) and unilateral in 16 (31%). Serum testosterone was quantified in 25 of 35 patients with follow up data, and was low in 2 (8%). Efavirenz was replaced with an alternative antiretroviral in 29/35 patients (83%) and gynaecomastia improved in 20/29 (69%). Gynaecomastia was a frequently reported ADR in our setting, occurring with prolonged efavirenz exposure. Testosterone was low in the minority of tested cases. Most clinicians elected to switch patients off efavirenz, and gynaecomastia improved in the majority.
- 16 November 2016
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 13 (1) , 1-5
Open AccessCases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
Gynaecomastia is associated with exposure to antiretroviral therapy (ART), in particular efavirenz. There is limited data on clinical characteristics of patients with ART-associated gynaecomastia in resource-limited settings and little guidance on the optimal management of this adverse drug reaction (ADR). We describe the clinical characteristics, management and outcomes of gynaecomastia cases reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa. We identified all gynaecomastia cases in adolescent boys and men on ART reported to the hotline between June 2013 and July 2014. We collected follow up data telephonically at monthly intervals to document clinical management and outcomes. We received 51 reports of gynaecomastia between June 2013 and July 2014; 11% of the 475 patient-specific ADR queries to the hotline. All patients were on efavirenz-based ART. Mean age was 34 years (standard deviation 12) and seven were adolescents. The median onset of gynaecomastia was 15 months after efavirenz initiation (interquartile range 6–42). Gynaecomastia was bilateral in 29 patients (57%) and unilateral in 16 (31%). Serum testosterone was quantified in 25 of 35 patients with follow up data, and was low in 2 (8%). Efavirenz was replaced with an alternative antiretroviral in 29/35 patients (83%) and gynaecomastia improved in 20/29 (69%). Gynaecomastia was a frequently reported ADR in our setting, occurring with prolonged efavirenz exposure. Testosterone was low in the minority of tested cases. Most clinicians elected to switch patients off efavirenz, and gynaecomastia improved in the majority.
- Open Access
- 1 January 2011
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 8 (1) , 4
The impact of the National HIV Health Care Worker Hotline on patient care in South Africa
South Africa has a huge burden of illness due to HIV infection. Many health care workers managing HIV infected patients, particularly those in rural areas and primary care health facilities, have minimal access to information resources and to advice and support from experienced clinicians. The Medicines Information Centre, based in the Division of Clinical Pharmacology at the University of Cape Town, has been running the National HIV Health Care Worker (HCW) Hotline since 2008, providing free information for HIV treatment-related queries via telephone, fax and e-mail.
- 1 January 2011
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 8 (1) , 4
Open AccessThe impact of the National HIV Health Care Worker Hotline on patient care in South Africa
South Africa has a huge burden of illness due to HIV infection. Many health care workers managing HIV infected patients, particularly those in rural areas and primary care health facilities, have minimal access to information resources and to advice and support from experienced clinicians. The Medicines Information Centre, based in the Division of Clinical Pharmacology at the University of Cape Town, has been running the National HIV Health Care Worker (HCW) Hotline since 2008, providing free information for HIV treatment-related queries via telephone, fax and e-mail.